CEO Unni Hjelmaas was invited to present Lytix Biopharma at The Anglonordic Life Science Conference in London April 23rd 2015.





The Anglonordic Life Science Conference offers close and focused interaction for R&D companies in the medical technology and biotech sectors, and incorporates investment and partnering company pitches interspersed with plenary sessions and panel discussions.

By invitation only, participants are restricted to decision makers representing drug discovery, medtech, pharmaceuticals and investment firms. 100 biotechnology companies, 60 medtech/diagnostic and enabling technology companies from the Anglo-Nordic regions were invited - and 30 pharma companies and 70 investors from Europe and USA. Additionally, there was a Guest Country, Spain, who attended with a delegation of R&D companies and investment firms.